Post-pandemic Era-Global Human Vaccines Market 2015-2034, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
Summary
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
XYZResearch’s analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This research report indicated that the global Human Vaccines market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Human Vaccines Market by XYZResearch Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in Human Vaccines Market?
AstraZeneca plc
Bavarian Nordic
Bharat Biotech
CSL Limited
Emergent BioSolutions, Inc.
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co, Inc.
Mymetics
Novartis AG
Pfizer, Inc.
Sanofi S.A.
Shenzhen Kangtai Biological Products Co., Ltd.
Takeda Pharmaceutical Company Limited
...
Major Type of Human Vaccines Covered in XYZResearch report
Conjugate
Recombinant
Inactivated
Combination
Attenuated
Others
Application Segments Covered in XYZResearch Market
Pediatrics
Adolescents
Adults
Geriatrics
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Content
Table of Contents
Global Human Vaccines Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Conjugate -Product Introduction and Major Manufacturers
1.1.2 Recombinant -Product Introduction and Major Manufacturers
1.1.3 Inactivated -Product Introduction and Major Manufacturers
1.1.4 Combination -Product Introduction and Major Manufacturers
1.1.5 Attenuated -Product Introduction and Major Manufacturers
1.1.6 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Human Vaccines Status and Prospect (2015-2026)
2.1.1 China Human Vaccines Market Size and Growth Rate (2015-2026)
2.1.2 China Human Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Human Vaccines Status and Prospect (2015-2026)
2.2.1 EU Human Vaccines Market Size and Growth Rate (2015-2026)
2.2.2 EU Human Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Human Vaccines Status and Prospect (2015-2026)
2.3.1 USA Human Vaccines Market Size and Growth Rate (2015-2026)
2.3.2 USA Human Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Human Vaccines Status and Prospect (2015-2026)
2.4.1 Japan Human Vaccines Market Size and Growth Rate (2015-2026)
2.4.2 Japan Human Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Human Vaccines Status and Prospect (2015-2026)
2.5.1 India Human Vaccines Market Size and Growth Rate (2015-2026)
2.5.2 India Human Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Human Vaccines Status and Prospect (2015-2026)
2.6.1 Southeast Asia Human Vaccines Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Human Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Human Vaccines Status and Prospect (2015-2026)
2.7.1 South America Human Vaccines Market Size and Growth Rate (2015-2026)
2.7.2 South America Human Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Human Vaccines Status and Prospect (2015-2026)
2.8.1 Human Vaccines Market Size and Growth Rate (2015-2026)
2.8.2 Human Vaccines Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Human Vaccines Market Assessment by Segment
3.1 Global Human Vaccines Capacity and Growth Rate
3.2 Global Human Vaccines Sales by Type
3.3 Global Human Vaccines Sales Revenue by Type
3.4 Global Human Vaccines Consumption by Application
4 Global Human Vaccines Market Assessment by Regions
4.1 Global Human Vaccines Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Human Vaccines Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Human Vaccines Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Human Vaccines Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Human Vaccines Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Human Vaccines Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Human Vaccines Sales Market Share of Manufacturers (2019-2020)
6.3 Global Human Vaccines Sales Revenue Market Share of Manufacturers (2019-2020)
7 Human Vaccines Competitive Analysis
7.1 AstraZeneca plc
7.1.1 AstraZeneca plc Company Profiles
7.1.2 AstraZeneca plc Product Introduction
7.1.3 AstraZeneca plc Human Vaccines Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Bavarian Nordic
7.2.1 Bavarian Nordic Company Profiles
7.2.2 Bavarian Nordic Product Introduction
7.2.3 Bavarian Nordic Human Vaccines Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Bharat Biotech
7.3.1 Bharat Biotech Company Profiles
7.3.2 Bharat Biotech Product Introduction
7.3.3 Bharat Biotech Human Vaccines Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 CSL Limited
7.4.1 CSL Limited Company Profiles
7.4.2 CSL Limited Product Introduction
7.4.3 CSL Limited Human Vaccines Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Emergent BioSolutions, Inc.
7.5.1 Emergent BioSolutions, Inc. Company Profiles
7.5.2 Emergent BioSolutions, Inc. Product Introduction
7.5.3 Emergent BioSolutions, Inc. Human Vaccines Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 GlaxoSmithKline plc
7.6.1 GlaxoSmithKline plc Company Profiles
7.6.2 GlaxoSmithKline plc Product Introduction
7.6.3 GlaxoSmithKline plc Human Vaccines Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Company Profiles
7.7.2 Johnson & Johnson Product Introduction
7.7.3 Johnson & Johnson Human Vaccines Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Merck & Co, Inc.
7.8.1 Merck & Co, Inc. Company Profiles
7.8.2 Merck & Co, Inc. Product Introduction
7.8.3 Merck & Co, Inc. Human Vaccines Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 Mymetics
7.9.1 Mymetics Company Profiles
7.9.2 Mymetics Product Introduction
7.9.3 Mymetics Human Vaccines Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 Novartis AG
7.10.1 Novartis AG Company Profiles
7.10.2 Novartis AG Product Introduction
7.10.3 Novartis AG Human Vaccines Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
7.11 Pfizer, Inc.
7.12 Sanofi S.A.
7.13 Shenzhen Kangtai Biological Products Co., Ltd.
7.14 Takeda Pharmaceutical Company Limited
8 Conclusion
List of Figure
List of Tables and Figures
Figure Product Introduction
Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
Figure Global Human Vaccines Production Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Production of Each Type (2015-2026)
Table CAGR in Terms of Production of Each Application (2015-2026)
Table Global Human Vaccines Sales (K Unit) by Type (2015-2026)
Figure Global Human Vaccines Sales (K Unit) and Growth Rate (2015-2026)
Figure Global Human Vaccines Sales Market Share (%) by Type (2019 -2020)
Table Global Human Vaccines Sales Value (Million USD) by Type (2015-2026)
Figure Global Human Vaccines Sales Value (Million USD) and Growth Rate (2015-2026)
Figure Global Human Vaccines Sales Value Market Share (%) by Type (2019-2020)
Table Global Human Vaccines Sales (K Unit) by Application (2015-2026)
Figure China Human Vaccines Production Value (Million USD) and Growth Rate (2015-2026)
Table China Human Vaccines Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure EU Human Vaccines Production Value (Million USD) and Growth Rate (2015-2026)
Table EU Human Vaccines Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure North America Human Vaccines Production Value (Million USD) and Growth Rate (2015-2026)
Table North America Human Vaccines Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Japan Human Vaccines Production Value (Million USD) and Growth Rate (2015-2026)
Table Japan Human Vaccines Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure India Human Vaccines Production Value (Million USD) and Growth Rate (2015-2026)
Table India Human Vaccines Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Southeast Asia Human Vaccines Production Value (Million USD) and Growth Rate (2015-2026)
Table Southeast Asia Human Vaccines Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure South America Human Vaccines Production Value (Million USD) and Growth Rate (2015-2026)
Table South America Human Vaccines Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Middle East and Africa Human Vaccines Production Value (Million USD) and Growth Rate (2015-2026)
Table Middle East and Africa Human Vaccines Local Capacity, Import, Export and Local Consumption (2015-2020)
Table Global Human Vaccines Capacity (K Units) and Growth Rate (2015-2026)
Figure Global Human Vaccines Capacity (K Units) and Growth Rate (2015-2026)
Table Global Human Vaccines Sales (Unit) by Type (2015-2026)
Figure Global Human Vaccines Sales(Unit) and Growth Rate (2015-2026)
Table Sales Market Share (%) by Type (2019-2026)
Table Global Human Vaccines Sales Revenue (Million USD) by Type (2015-2026)
Figure Global Human Vaccines Sales Revenue (Million USD) and Growth Rate (2015-2026)
Table Sales Revenue Market Share (%) by Type (2019-2026)
Table Global Human Vaccines Consumption (Unit) by Application (2015-2026)
Figure Global Human Vaccines Consumption (Unit) and Growth Rate (2015-2026)
Table Consumption Market Share (%) by Application (2019-2026)
Table Global Human Vaccines Production (K Unite) by Regions (2015-2020)
Table Global Human Vaccines CAGR (%) in term of Production and Market Share by Regions (2015-2026)
Figure Global Human Vaccines Production Share by Regions (2019-2020)
Table Global Human Vaccines Sales (K Unite) by Regions (2015-2020)
Table Global Human Vaccines CAGR (%) in term of Sales and Market Share by Regions (2015-2026)
Figure Global Human Vaccines Sales Share by Regions (2019-2020)
Table Global Human Vaccines Sales Revenue (Million USD) by Regions (2015-2020)
Table Global Human Vaccines CAGR (%) in term of Sales Revenue and Market Share by Regions (2015-2026)
Figure Global Human Vaccines Sales Revenue Share by Regions (2019-2020)
Figure Value Chain Structure of Human Vaccines
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Human Vaccines
Figure Cost Structure of Human Vaccines in 2020
Table Global Human Vaccines Capacity Share of Manufacturers (2019-2020)
Figure Global Human Vaccines Capacity Share of Manufacturers (2019-2020)
Table Global Human Vaccines Sales Market Share of Manufacturers (2019-2020)
Figure Global Human Vaccines Sales Market Share of Manufacturers (2019-2020)
Table Global Human Vaccines Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Human Vaccines Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Human Vaccines Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
Table AstraZeneca plc Profiles
Table AstraZeneca plc Human Vaccines Product Introduction
Table AstraZeneca plc Human Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure AstraZeneca plc SWOT Analysis
Table Bavarian Nordic Profiles
Table Bavarian Nordic Human Vaccines Product Introduction
Table Bavarian Nordic Human Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Bavarian Nordic SWOT Analysis
Table Bharat Biotech Profiles
Table Bharat Biotech Human Vaccines Product Introduction
Table Bharat Biotech Human Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Bharat Biotech SWOT Analysis
Table CSL Limited Profiles
Table CSL Limited Human Vaccines Product Introduction
Table CSL Limited Human Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure CSL Limited SWOT Analysis
Table Emergent BioSolutions, Inc. Profiles
Table Emergent BioSolutions, Inc. Human Vaccines Product Introduction
Table Emergent BioSolutions, Inc. Human Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Emergent BioSolutions, Inc. SWOT Analysis
Table GlaxoSmithKline plc Profiles
Table GlaxoSmithKline plc Human Vaccines Product Introduction
Table GlaxoSmithKline plc Human Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure GlaxoSmithKline plc SWOT Analysis
Table Johnson & Johnson Profiles
Table Johnson & Johnson Human Vaccines Product Introduction
Table Johnson & Johnson Human Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Johnson & Johnson SWOT Analysis
Table Merck & Co, Inc. Profiles
Table Merck & Co, Inc. Human Vaccines Product Introduction
Table Merck & Co, Inc. Human Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Merck & Co, Inc. SWOT Analysis
Table Mymetics Profiles
Table Mymetics Human Vaccines Product Introduction
Table Mymetics Human Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Mymetics SWOT Analysis
Table Novartis AG Profiles
Table Novartis AG Human Vaccines Product Introduction
Table Novartis AG Human Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Novartis AG SWOT Analysis
Table Pfizer, Inc. Profiles
Table Pfizer, Inc. Human Vaccines Product Introduction
Table Pfizer, Inc. Human Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Pfizer, Inc. SWOT Analysis
Table Sanofi S.A. Profiles
Table Sanofi S.A. Human Vaccines Product Introduction
Table Sanofi S.A. Human Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Sanofi S.A. SWOT Analysis
Table Shenzhen Kangtai Biological Products Co., Ltd. Profiles
Table Shenzhen Kangtai Biological Products Co., Ltd. Human Vaccines Product Introduction
Table Shenzhen Kangtai Biological Products Co., Ltd. Human Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Shenzhen Kangtai Biological Products Co., Ltd. SWOT Analysis
Table Takeda Pharmaceutical Company Limited Profiles
Table Takeda Pharmaceutical Company Limited Human Vaccines Product Introduction
Table Takeda Pharmaceutical Company Limited Human Vaccines Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Takeda Pharmaceutical Company Limited SWOT Analysis